(MSOS) AdvisorShares Pure US - Ratings and Ratios

The AdvisorShares Pure US Cannabis ETF (NYSE ARCA: MSOS) is an actively managed exchange-traded fund designed to provide exposure to companies operating in the U.S. cannabis and hemp industries. Under normal market conditions, the fund allocates at least 80% of its net assets (including borrowings for investment purposes) to securities of firms that generate at least 50% of their revenue from marijuana and hemp-related businesses in the United States. This includes direct industry participants, such as cultivators, dispensaries, and ancillary service providers. The fund also invests in derivatives that economically resemble these securities, offering a diversified exposure to the sector.

The ETF maintains a significant concentration in the pharmaceuticals, biotechnology, and life sciences industry group within the healthcare sector, accounting for at least 25% of its portfolio. This reflects the growing intersection of cannabis with medical research and therapeutic applications. As a non-diversified fund, it may hold a smaller number of securities, which can result in higher volatility but also allows for targeted exposure to key players in the U.S. cannabis market.

From a technical perspective, MSOS is currently trading below its 20-day, 50-day, and 200-day moving averages, indicating bearish momentum. The average true range (ATR) of 0.17 suggests moderate volatility, while the average 20-day volume of 5,091,410 shares reflects decent liquidity. Resistance levels at 4.4, 4.1, and 3.5 may act as near-term hurdles for the price.

Fundamentally, the ETF has assets under management (AUM) of $458.08 million, making it one of the larger funds focused on the U.S. cannabis sector. However, the industry remains subject to regulatory uncertainties and competitive pressures, which could impact performance.